• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA NEARPORT 20GA X 1.00IN W/ MAXZERO; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA NEARPORT 20GA X 1.00IN W/ MAXZERO; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 393526
Medical Device Problem Code Retraction Problem (1536)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 01/20/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that bd nexiva nearport 20ga x 1.00in w/ maxzero needle retraction failed.It was reported by customer that customer was unable to remove needle following iv placement.Safety mechanism seemed to jam, and the clinician had to forcefully remove the needle after a few minutes of trouble shooting.Customer was unable to remove needle following iv placement.Safety mechanism seemed to jam, and the clinician had to forcefully remove the needle after a few minutes of trouble shooting.
 
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Additional Manufacturer Narrative
Investigation results: our quality engineer inspected the 1 activated physical sample submitted for evaluation.The reported issue of needle retraction failure was not confirmed upon inspection of the sample.Analysis of the sample showed that the piece was manipulated, exposing the cannula and activating safety system, but there was no damage was observed to the cannula that could be related to the reported failure.Bd could not determine a manufacturing related root cause since the reported defect was not confirmed during the evaluation of the sample.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.Production records were reviewed, and this batch meets our manufacturing specification requirements.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.
 
Event or Problem Description
No additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA NEARPORT 20GA X 1.00IN W/ MAXZERO
Common Device Name
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key21344964
Report Number9610847-2025-00020
Device Sequence Number15681572
Product Code FOZ
UDI-Device Identifier00382903935260
UDI-Public(01)00382903935260(11)240923(17)270831(10)4247493
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
K231239
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/14/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number393526
Device Lot Number4247493
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/21/2025
Supplement Date Received by Manufacturer03/14/2025
Initial Report FDA Received Date02/10/2025
Supplement Report FDA Received Date03/18/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/23/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-